speb/financial-data huggingface dataset:
Financial scorecard for SANATHAN.NS (Consumer Cyclical — Textile Manufacturing, India)
Report date: 2026-03-31 (annual)
Stock price: 4.985549132947977
Market cap: 40767160320 (USD: 432038579.0589233)
P/E ratio: 0.42254715771094253
P/B ratio: 1.6502397609289343
Debt to equity: 0.8077
Current ratio: 1.07
Interest coverage ratio: 1.995305164319249
Return on net tangible assets (%): -22.26472224599846
Buffett classification: The Gruesome
Analyst consensus upside (%): 14078.974568203455
Rule of 40 score: 7.538347571986133
Altman Z-score: 1.8286429820314785 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 1.9627893765090185, earnings yield % 0.012176410454308515, rank 2858
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -7.749414024626063
Total shareholder yield (%): -7.749414024626063 (Minimal or Negative)
Momentum (%): 1m 5.814375398369608, 3m 8.245479040658461, 6m 6.058754324515975, 12m -19.23662790162085, composite -3.1234155950858047 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 1, short score 6, recommendation: Neutral
Revenue growth 1y (%): 44.758751820606776
Net income growth 1y (%): -55.2031774195193
Revenue deceleration: no
Accrual ratio: 0.08585179116185139
FCF conversion rate: -3.775694893341952
Beneish M-score: -1.8029504614572431 (Likely Safe)
ROE (%): 4.001031123199738
Net margin (%): 2.029555150898147
Asset turnover: 0.8857515685983345
Equity multiplier (leverage): 2.2256616483568252
ROE archetype: Low Return
P/E z-score: 3.2523803021878965
Treasury beta 1y: 0.07206072899777458 (R-squared: 0.00515233653105879)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 4.01402124104225 (pretax: 5.95746138942017)
Incremental ROIC 3y (%): -3.9625566716136373 (pretax: -4.602957015327657)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 52.02702702702703, P/B 59.45945945945946, ROIC 50.67567567567568, revenue growth 1y 3.3783783783783785, 6m momentum 33.108108108108105
Sector percentiles: P/E 30.285118219749652, 6m momentum 24.02642559109875
Industry median P/E: 0.18251138762789332; industry median ROIC: 4.332358383927475
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.10166830439477971
Base cash flow: -44106612.97159813
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SENORES.NS (Healthcare — Drug Manufacturers - General, India)
Report date: 2026-03-31 (annual)
Stock price: 14.321841453344344
Market cap: 63899353088 (USD: 677186870.3688004)
P/E ratio: 0.30403448477922357
P/B ratio: 3.6107665667701045
Debt to equity: 0.3546
Current ratio: 1.92
Interest coverage ratio: 5.476228525769077
Return on net tangible assets (%): -20.386313063145227
Buffett classification: The Gruesome
Analyst consensus upside (%): 14551.84505002633
Rule of 40 score: 11.9665668387793
Altman Z-score: 6.475848972868683 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 5.0842719067018125, earnings yield % 0.007071598408851171, rank 2439
Dividend yield (%): 0
Buyback yield (%): 0.029890756442707847
Debt paydown yield (%): 0.08096739748930495
Total shareholder yield (%): 0.1108581539320128 (Low Return)
Momentum (%): 1m 6.939112695482448, 3m 51.24597421020436, 6m 63.50471364940251, 12m 82.27990006171486, composite 61.734242904880375 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 4, short score 2, recommendation: Neutral
Revenue growth 1y (%): 39.0549633048809
Net income growth 1y (%): 84.98825110759938
Revenue deceleration: no
Beneish M-score: 1.9907166286802047 (Strong Manipulation Signal)
ROE (%): 13.063943430066141
Net margin (%): 19.21028089088409
Asset turnover: 0.4278616122238955
Equity multiplier (leverage): 1.5894148001455746
ROE archetype: Standard Business
P/E z-score: 3.144765767479274
Treasury beta 1y: -0.0003382997951525323 (R-squared: 1.1535291850842845e-05)
Insider 90-day net shares: 6450 (net value USD: 58787.00)
ROIC (%): 10.746621263575465 (pretax: 14.068850843699963)
Incremental ROIC 3y (%): 11.316965546211337 (pretax: 14.650082340011519)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 16.666666666666664, P/B 36.11111111111111, ROIC 56.94444444444444, revenue growth 1y 6.944444444444445, 6m momentum 2.7777777777777777
Sector percentiles: P/E 8.273638968481375, 6m momentum 4.333810888252149
Industry median P/E: 16.627450980392158; industry median ROIC: 15.669270196462376
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10187392084063605
Base cash flow: -11845061.466723189
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SEPN (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 33.1
Market cap: 1492000000 (USD: 1492000000)
P/B ratio: 2.862048253676762
Debt to equity: 0.061
Current ratio: 4.71
Return on net tangible assets (%): -2.390754059895682
Buffett classification: The Gruesome
Analyst consensus upside (%): 87.26591760299624
Rule of 40 score: 9337.499191049155
Altman Z-score: 4.829176921433251 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.03585790884718499
Total shareholder yield (%): 0.03585790884718499 (Low Return)
Momentum (%): 1m -8.183079056865454, 3m 34.171057965139845, 6m 28.493788819875775, 12m 144.1002949852507, composite 76.17343467071807 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 12010.95890410959
Revenue deceleration: no
Accrual ratio: 0.030583038490404203
FCF conversion rate: 3.064142642121107
Beneish M-score: 81.34142355606711 (Strong Manipulation Signal)
ROE (%): -2.2717469068260248
Net margin (%): -32.56418957131546
Asset turnover: 0.045498874236088775
Equity multiplier (leverage): 1.5332713471088293
ROE archetype: Low Return
FCF z-score: 1.4943701129867948
Treasury beta 1y: -0.004010808558271745 (R-squared: 0.0007250826992148011)
Insider 90-day net shares: -48494 (net value USD: -1605268.00)
ROIC (%): -441.36101507398695 (pretax: -558.6848292075784)
Incremental ROIC 3y (%): -47.1270325203252 (pretax: -59.65447154471545)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 32.03971119133574, ROIC 37.18411552346571, revenue growth 1y 0.09025270758122744, 6m momentum 12.815884476534295
Sector percentiles: P/E , 6m momentum 11.103151862464184
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10099493501940288
Base cash flow: -47793000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SETL.NS (Industrials — Specialty Industrial Machinery, India)
Report date: 2026-03-31 (annual)
Stock price: 2.814822460776218
Market cap: 55066697728 (USD: 583580942.4332345)
P/E ratio: 0.27797671889068215
P/B ratio: 2.6625436965175644
Debt to equity: 0.10369999999999999
Current ratio: 2.4
Interest coverage ratio: 9.580321584099453
Return on net tangible assets (%): 5.059043112068545
Buffett classification: The Good
Rule of 40 score: 12.260806336060895
Altman Z-score: 8.700659634681246 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 3.523238157137696, earnings yield % 0.005426743127247418, rank 2741
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.14310245333138982
Total shareholder yield (%): -0.14310245333138982 (Minimal or Negative)
Momentum (%): 1m 19.466156165468856, 3m 91.68085512565115, 6m 112.15438303314991, 12m 36.69870193416067, composite 72.75328792604894 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 5, short score 2, recommendation: Neutral
Revenue growth 1y (%): 23.54468434466439
Net income growth 1y (%): 15.86497961073421
Revenue deceleration: no
Beneish M-score: 2.3578443863837237 (Strong Manipulation Signal)
ROE (%): 10.48517231928463
Net margin (%): 10.727258846048164
Asset turnover: 0.6699198855101848
Equity multiplier (leverage): 1.4590290628035028
ROE archetype: Standard Business
P/E z-score: 0.10314242541780042
Treasury beta 1y: 0.14171651617716285 (R-squared: 0.008728684154102833)
Insider 90-day net shares: 16606 (net value USD: 30802.00)
ROIC (%): 12.026893183935481 (pretax: 16.10582642597724)
Incremental ROIC 3y (%): 2.481515843349855 (pretax: 3.218954604280518)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 33.71868978805395, P/B 51.445086705202314, ROIC 31.213872832369944, revenue growth 1y 9.05587668593449, 6m momentum 1.348747591522158
Sector percentiles: P/E 29.544290834613413, 6m momentum 1.6641065028161803
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10189922957320507
Base cash flow: 4057725.7312420504
DCF price per share: base 0.0023309087937541393, conservative 0.0016402682738785072, aggressive 0.003424079520473881
Financial scorecard for SHADOWFAX.NS (Industrials — Integrated Freight & Logistics, India)
Report date: 2026-03-31 (annual)
Stock price: 2.213872832369942
Market cap: 125539377152 (USD: 1330430024.925816)
P/E ratio: 0.5534084700835677
P/B ratio: 3.8363252350881947
Debt to equity: 0.1416
Current ratio: 1.84
Interest coverage ratio: 4.752012072434607
Return on net tangible assets (%): 2.6649977518258825
Buffett classification: The Gruesome
Analyst consensus upside (%): 20115.1127361365
Rule of 40 score: 56.699570845356256
Altman Z-score: 7.723020872854136 (Safe Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 3.703434167010326, earnings yield % 0.00410662133605055, rank 2735
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.8062299353727076
Total shareholder yield (%): -0.8062299353727076 (Minimal or Negative)
Momentum (%): 1m -7.867423293703335, 3m 38.381756279446904, 6m 84.24784537808767, 12m , composite 61.31480082876729 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 4, short score 1, recommendation: Neutral
Revenue growth 1y (%): 53.29702375366665
Net income growth 1y (%): 1474.9341227831337
Revenue CAGR 3y (%): 37.22105373075104
Revenue deceleration: no
Revenue growth consistency score: 13.608819276438146
Beneish M-score: -1.8892967377562742 (Likely Safe)
ROE (%): 4.497657591332493
Net margin (%): 4.513010371112854
Asset turnover: 0.5649088863220811
Equity multiplier (leverage): 1.7641749507261364
ROE archetype: Low Return
P/E z-score: 1.3782074867535912
FCF z-score: 0.9534456160707659
Treasury beta 1y: -0.000278457985090752 (R-squared: 1.2222096314007018e-05)
Insider 90-day net shares: -99015 (net value USD: -129609.00)
ROIC (%): 8.559420589044867 (pretax: 10.834709606385909)
Incremental ROIC 3y (%): 17.42193133783616 (pretax: 22.053077642830583)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 31.16883116883117, P/B 69.48051948051948, ROIC 24.025974025974026, revenue growth 1y 1.948051948051948, 6m momentum 0.6493506493506493
Sector percentiles: P/E 34.4342037890425, 6m momentum 2.61136712749616
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10189200543631267
Base cash flow: 4648155.998304367
DCF price per share: base 0.0023821162032471523, conservative 0.001752898687707332, aggressive 0.00349245941925445
Financial scorecard for SHAW.L (Financial Services — Banks - Regional, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0472
Market cap: 1839692800 (USD: 2486071351.3513513)
P/E ratio: 0.18764478764478768
P/B ratio: 0.013707897623120763
Debt to equity: 0.3303120759837178
Return on net tangible assets (%): 13.054753344728004
Buffett classification: The Gruesome
Analyst consensus upside (%): 752751.0288065842
Rule of 40 score: 169.21801918794992
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 4.422341599640984
Total shareholder yield (%): 4.422341599640984 (Moderate Return)
Momentum (%): 1m 8.703030303030292, 3m 2.428152492668617, 6m -23.23516483516483, 12m , composite -10.403506171248107 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 5, short score 0, recommendation: Neutral
Revenue growth 1y (%): 20.56190993326443
Net income growth 1y (%): -3.887516438676053
Revenue deceleration: no
Revenue growth consistency score: 12.781508362647545
Accrual ratio: -0.04194299783008358
FCF conversion rate: 5.367263427109974
Beneish M-score: -2.2750417843428723 (Likely Safe)
Equity multiplier (leverage): 12.118889160290975
ROE archetype: Standard Business
P/E z-score: 2.059787657274742
FCF z-score: 2.0597876572747413
Treasury beta 1y: 0.00017038713239163287 (R-squared: 3.952613072724066e-06)
Insider 90-day net shares: 2954 (net value USD: 13307.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 18.012422360248447, P/B 2.018633540372671, ROIC , revenue growth 1y 13.043478260869565, 6m momentum 92.08074534161491
Sector percentiles: P/E 9.544749094671495, 6m momentum 61.2002069322297
Industry median P/E: 10.091388400702987; industry median ROIC: 0.8427644093631484
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.15
Base cash flow: 299324324.32432437
DCF price per share: base 0.2579609391284836, conservative 0.18510815318509033, aggressive 0.37911862310953515
Financial scorecard for SHAZ (Technology — Information Technology Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 64.89
Market cap: 2306279424 (USD: 2306279424)
P/B ratio: 9.044903609546843
Debt to equity: 2.3047
Current ratio: 1.04
Return on net tangible assets (%): -86.32827343320359
Buffett classification: The Gruesome
Analyst consensus upside (%): 408.1390233172019
Rule of 40 score: -17143.416782579665
Altman Z-score: 5.833789280914417 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.9486380224497895
Total shareholder yield (%): -2.9486380224497895 (Minimal or Negative)
Momentum (%): 1m -22.463854701875967, 3m 53.8042190092439, 6m , 12m , composite 53.8042190092439 ()
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 13, recommendation: Short
Revenue growth 1y (%): -9.559755392319714
Revenue deceleration: no
Accrual ratio: 0.13446053478444048
FCF conversion rate: 2.5090409787944865
Beneish M-score: 0.12374070404967749 (Strong Manipulation Signal)
ROE (%): -50.75207277886589
Net margin (%): -6773.746828382322
Asset turnover: 0.0013154212097820784
Equity multiplier (leverage): 5.695868881144097
ROE archetype: Low Return
Treasury beta 1y: -0.02478766820161636 (R-squared: 0.01787836051330297)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -21.24451242339605 (pretax: -26.891787877716517)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 71.97452229299363, ROIC 78.343949044586, revenue growth 1y 43.31210191082803, 6m momentum 
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05
Base cash flow: -46715245
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SHC (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 17.35
Market cap: 4947647488 (USD: 4947647488)
P/E ratio: 34.97560975609756
P/B ratio: 6.569095338929005
Debt to equity: 3.6472
Current ratio: 2.82
Interest coverage ratio: 2.1823859548136424
Return on net tangible assets (%): -1.4893583181132586
Buffett classification: The Good
Analyst consensus upside (%): 42.538354253835436
Rule of 40 score: -18.824158443535953
Altman Z-score: 1.221320712433471 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 4.87785579425094, earnings yield % 1.09835428400832, rank 1291
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.06863868147916038
Total shareholder yield (%): 0.06863868147916038 (Low Return)
Momentum (%): 1m 3.9544637507489524, 3m 11.360718870346608, 6m -6.266882766072393, 12m 43.270024772914965, composite 14.304606529665868 (Strong Uptrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 0, short score 8, recommendation: Short
Revenue growth 1y (%): 10.027384558566421
Revenue deceleration: no
Accrual ratio: 0.013331101225279609
FCF conversion rate: -0.6292451765767799
Beneish M-score: -2.4216036856419825 (Likely Safe)
ROE (%): 4.328552590880232
Net margin (%): 9.494545519470085
Asset turnover: 0.08617978399430812
Equity multiplier (leverage): 5.2900906767382425
ROE archetype: Low Return
P/E z-score: 3.9011495780011134
FCF z-score: 3.8979060755377297
Treasury beta 1y: -0.002349539222939672 (R-squared: 0.000692830451716524)
Insider 90-day net shares: -56838253 (net value USD: -864672622.00)
ROIC (%): 9.282677735933605 (pretax: 14.281042670667087)
Incremental ROIC 3y (%): 7.139695000556569 (pretax: 20.745217618216024)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 36.029411764705884, P/B 60.29411764705882, ROIC 23.52941176470588, revenue growth 1y 30.14705882352941, 6m momentum 41.17647058823529
Sector percentiles: P/E 29.083094555873924, 6m momentum 36.49713467048711
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1132046572690823
Base cash flow: 76637000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SITE (Industrials — Industrial Distribution, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 99.87
Market cap: 4425062912 (USD: 4425062912)
P/E ratio: 39.38165680473373
P/B ratio: 3.578586470596445
Debt to equity: 0.6873
Current ratio: 2.33
Interest coverage ratio: -3.2375
Return on net tangible assets (%): -1.1799051210315046
Buffett classification: The Gruesome
Analyst consensus upside (%): 18.00766283524904
Rule of 40 score: -27.566764698964533
Altman Z-score: 2.558854846789734 (Grey Zone)
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 13.5161217075386, earnings yield % 4.328883978991875, rank 2591
Dividend yield (%): 0
Buyback yield (%): 0.45197097527728886
Debt paydown yield (%): -3.450798396242101
Total shareholder yield (%): -2.9988274209648123 (Minimal or Negative)
Momentum (%): 1m -10.45458620998834, 3m -31.166861947756562, 6m -32.291525423728814, 12m -23.908571428571427, composite -26.16104975874909 (Strong Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 0.07451564828613311
Revenue deceleration: no
Accrual ratio: 0.037740935436042594
FCF conversion rate: 6.228215767634855
Beneish M-score: -2.308621922100208 (Likely Safe)
ROE (%): -1.4468825983850149
Net margin (%): -2.563557068396979
Asset turnover: 0.28158931272558446
Equity multiplier (leverage): 2.004352655119623
ROE archetype: Low Return
P/E z-score: 4.163348070652707
FCF z-score: 4.1633480706527
Treasury beta 1y: -0.0019114189154034057 (R-squared: 0.000394025408634452)
Insider 90-day net shares: 875 (net value USD: 119146.00)
ROIC (%): 7.462774778684176 (pretax: 9.629539755722721)
Incremental ROIC 3y (%): -16.666869988336476 (pretax: -20.683649031134337)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 66.29213483146067, P/B 64.04494382022472, ROIC 51.68539325842697, revenue growth 1y 35.95505617977528, 6m momentum 86.51685393258427
Sector percentiles: P/E 61.930363543266765, 6m momentum 77.11213517665131
Industry median P/E: 2.3870967741935485; industry median ROIC: 9.146184366209983
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10658815688997966
Base cash flow: 254100000
DCF price per share: base 70.96431981859975, conservative 53.20783188415321, aggressive 94.14214203354244
Financial scorecard for SLX.AX (Technology — Semiconductors, Australia)
Report date: 2025-06-30 (annual)
Stock price: 3.236111111111111
Market cap: 1296890752 (USD: 847641014.379085)
P/B ratio: 12.913305234745089
Debt to equity: 0.0034999999999999996
Current ratio: 31.31
Interest coverage ratio: -141.78643820795335
Return on net tangible assets (%): -46.4195526432742
Buffett classification: The Gruesome
Analyst consensus upside (%): 349.21090047393363
Rule of 40 score: 51.092349579717734
Altman Z-score: 93.31322941095996 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.022778285645451195
Total shareholder yield (%): 0.022778285645451195 (Low Return)
Momentum (%): 1m -16.35719944543475, 3m -28.427242408285057, 6m -33.91996891996892, 12m 2.6581465919701337, composite -13.204407060156901 (Moderate Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE (%): -37.74059722338387
Net margin (%): -626.5422353846515
Asset turnover: 0.05582363708097763
Equity multiplier (leverage): 1.0790468156125776
ROE archetype: Low Return
FCF z-score: 3.7045016785853693
Treasury beta 1y: 0.007531061739898227 (R-squared: 0.0014039493200601327)
Insider 90-day net shares: -2192007 (net value USD: -10487450.00)
ROIC (%): -102.4882559459201 (pretax: -129.7319695517976)
Incremental ROIC 3y (%): -303.58457891648254 (pretax: -384.2842771094715)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 68.51851851851852, ROIC 80.8641975308642, revenue growth 1y , 6m momentum 82.09876543209876
Sector percentiles: P/E , 6m momentum 68.5352018685352
Industry median P/E: 31.956834532374103; industry median ROIC: 3.679818125534067
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.07550142871502705
Base cash flow: -27593198.039215688
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SNYR (Healthcare — Medical Distribution, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.17
Market cap: 2540430 (USD: 2540430)
Debt to equity: -1.0922559707147146
Current ratio: 0.93
Interest coverage ratio: -0.2818518369422117
Buffett classification: The Gruesome
Rule of 40 score: -48.781339243024995
Altman Z-score: -12.27069957197872 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -36.780190755108386
Total shareholder yield (%): -36.780190755108386 (Minimal or Negative)
Momentum (%): 1m -19.047619047619037, 3m -57.49999999999999, 6m -90.86021505376345, 12m -95.71788413098237, composite -81.02351416989428 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): -32.774222590592
Net income growth 1y (%): -393.1649594186227
Revenue deceleration: no
Accrual ratio: -0.06306051251034
FCF conversion rate: 0.7959355350288198
Beneish M-score: -2.2727858969607997 (Likely Safe)
Net margin (%): -46.769287627862774
Asset turnover: 0.6607381092480215
ROE archetype: Standard Business
Treasury beta 1y: 0.007959384912322428 (R-squared: 0.0016946854820008763)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -133.47912630026028 (pretax: -168.9609193674181)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 75.80645161290323, revenue growth 1y 43.54838709677419, 6m momentum 83.87096774193549
Sector percentiles: P/E , 6m momentum 79.97851002865329
Industry median P/E: 0.9833576287657921; industry median ROIC: 6.89479587953176
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12665261548625195
Base cash flow: -12207874
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SOC (Energy — Oil & Gas Drilling, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 4.72
Market cap: 902909696 (USD: 902909696)
P/B ratio: 7.506923928953238
Debt to equity: 2.3219
Current ratio: 0.08
Interest coverage ratio: -3.425464405215184
Return on net tangible assets (%): -50.671663549540966
Buffett classification: The Gruesome
Analyst consensus upside (%): -19.309927360774815
Rule of 40 score: -9307.63178599528
Altman Z-score: -1.556858344307273 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.9967452071751812
Total shareholder yield (%): -3.9967452071751812 (Minimal or Negative)
Momentum (%): 1m -40.47919293820934, 3m -65.24300441826215, 6m -54.74592521572388, 12m -83.53105373342639, composite -64.10656807757664 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 13, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.054024774224480106
FCF conversion rate: 0.5241643234903007
Beneish M-score: -2.6229848150680826 (Likely Safe)
ROE (%): -41.21167245018125
Net margin (%): -15501.652242328877
Asset turnover: 0.0007324162475394041
Equity multiplier (leverage): 3.629813233267027
ROE archetype: Low Return
Treasury beta 1y: -0.0018343341869949173 (R-squared: 2.6645654102127717e-05)
Insider 90-day net shares: -1077406 (net value USD: -17201812.00)
ROIC (%): -23.372163564204623 (pretax: -29.58501716987927)
Incremental ROIC 3y (%): -28.71515736819869 (pretax: -36.34830046607429)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 76.66666666666667, ROIC 100, revenue growth 1y , 6m momentum 100
Sector percentiles: P/E , 6m momentum 76.61050545094153
Industry median P/E: 7.611445322012008; industry median ROIC: 3.511361549743291
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.05358245682424749
Base cash flow: -813276000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SPT (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.49
Market cap: 454998912 (USD: 454998912)
P/B ratio: 1.4387389362888612
Debt to equity: 0.2163
Current ratio: 0.95
Interest coverage ratio: -8.764617691154422
Return on net tangible assets (%): -34.347947500698126
Buffett classification: The Gruesome
Analyst consensus upside (%): 69.64912280701753
Rule of 40 score: 5.418305045542898
Altman Z-score: -0.00723140247287693 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.7942900048077477
Total shareholder yield (%): 1.7942900048077477 (Low Return)
Momentum (%): 1m 11.791044776119403, 3m 25.041736227045075, 6m -23.571428571428573, 12m -60.72364971158888, composite -21.131991487631417 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 6, short score 12, recommendation: Short
Revenue growth 1y (%): 11.170383112664585
Revenue deceleration: no
Accrual ratio: -0.059036891999302094
FCF conversion rate: -3.806344696969697
Beneish M-score: -3.0154590567538078 (Likely Safe)
ROE (%): -3.0271468567551816
Net margin (%): -5.2149435788537986
Asset turnover: 0.23553690169241803
Equity multiplier (leverage): 2.464477845833373
ROE archetype: Low Return
FCF z-score: 4.431825339990108
Treasury beta 1y: 0.01956154066894524 (R-squared: 0.019757004863129105)
Insider 90-day net shares: -131641 (net value USD: -964444.00)
ROIC (%): -21.07646448459843 (pretax: -26.679068967846113)
Incremental ROIC 3y (%): 3.7857350987202496 (pretax: 4.792069745215506)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 21.96765498652291, ROIC 62.129380053908356, revenue growth 1y 29.514824797843666, 6m momentum 56.06469002695418
Sector percentiles: P/E , 6m momentum 58.19152485819152
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09549173038842666
Base cash flow: -35103000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SPTX (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 21
Market cap: 1129494656 (USD: 1129494656)
Debt to equity: 0.0255
Current ratio: 13.24
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 1.6346920410341679 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 8.751941998964273, 3m , 6m , 12m , composite  ()
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.022997896105379206
FCF conversion rate: 0.7939231738035264
Beneish M-score: -0.875237906666007 (Strong Manipulation Signal)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: -0.45397825808207054 (R-squared: 0.14887921375691116)
Insider 90-day net shares: 1113000 (net value USD: 20035768.00)
Capital allocation category: Standard Allocator
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.052851
Base cash flow: -73832000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SSTI (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.52
Market cap: 107129064 (USD: 107129064)
P/B ratio: 1.2684159114306
Debt to equity: 0.0861
Current ratio: 0.77
Return on net tangible assets (%): -126.00119545726241
Buffett classification: The Gruesome
Analyst consensus upside (%): 96.37462235649546
Rule of 40 score: -18.9922245597495
Altman Z-score: -0.32961758803396823 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.1642878164230017
Total shareholder yield (%): 0.1642878164230017 (Low Return)
Momentum (%): 1m -9.397590361445795, 3m 12.07153502235469, 6m 1.4844804318488452, 12m -39.35483870967742, composite -6.50283355827624 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 16, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -14.713041024374762
Revenue deceleration: no
Accrual ratio: -0.04197660232752917
FCF conversion rate: 0.21655960028551036
Beneish M-score: -2.9049024800191994 (Likely Safe)
ROE (%): -10.022893117756475
Net margin (%): -28.97261973695095
Asset turnover: 0.1849326332133747
Equity multiplier (leverage): 1.8706467305766203
ROE archetype: Low Return
FCF z-score: 4.14627760127837
Treasury beta 1y: 0.005735582667657644 (R-squared: 0.0017001723523018784)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -10.809859719438878 (pretax: -13.683366733466935)
Incremental ROIC 3y (%): -65.43032570501644 (pretax: -83.98727465535525)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 19.81132075471698, ROIC 57.27762803234502, revenue growth 1y 52.56064690026954, 6m momentum 21.159029649595688
Sector percentiles: P/E , 6m momentum 30.196863530196865
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.1037593407242104
Base cash flow: -4019000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for STRR.V (Basic Materials — Other Precious Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.34507042253521125
Market cap: 39396220 (USD: 28342604.316546764)
P/B ratio: 2.235465971306334
Debt to equity: 0
Current ratio: 7.41
Return on net tangible assets (%): -0.11891085166990104
Buffett classification: The Gruesome
Rule of 40 score: -310.1005727711301
Altman Z-score: 46.53711050329486 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -7.760021668472391, 3m -5.951394642364005, 6m 40.05799502899748, 12m 104.04164115125536, composite 51.77132743572802 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 14.802844249370196
Revenue deceleration: no
Revenue growth consistency score: 3.878751480255984
Accrual ratio: 0.018313444803026036
FCF conversion rate: 3.090835497885921
Beneish M-score: -1.571169526293449 (Possible Manipulation)
ROE (%): -0.9097855012119325
Net margin (%): -95.84589278138745
Asset turnover: 0.009138536943565506
Equity multiplier (leverage): 1.0386968928322702
ROE archetype: Low Return
Treasury beta 1y: -0.008113951954046822 (R-squared: 0.004207771519172072)
Insider 90-day net shares: 55000 (net value USD: 19665.00)
ROIC (%): -12.750411420532961 (pretax: -16.139761291813876)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 21.48997134670487, ROIC 26.36103151862464, revenue growth 1y 9.455587392550143, 6m momentum 4.584527220630372
Sector percentiles: P/E , 6m momentum 5.496946141032759
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07165
Base cash flow: -6564177.372262773
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for STTK (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.43
Market cap: 709625664 (USD: 709625664)
P/B ratio: 6.408071173892628
Debt to equity: 0.0302
Current ratio: 22.07
Return on net tangible assets (%): -14.479052538216727
Buffett classification: The Gruesome
Analyst consensus upside (%): 123.63919129082429
Rule of 40 score: 0
Altman Z-score: 62.178662324260245 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.06595026416631967
Total shareholder yield (%): -0.06595026416631967 (Minimal or Negative)
Momentum (%): 1m 23.627287853577368, 3m -4.005167958656338, 6m 79.03614457831323, 12m 754.0229885057471, composite 221.94519144026876 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.013906506443278953
FCF conversion rate: 0.9090539716936412
Beneish M-score: -2.431812611488721 (Likely Safe)
ROE (%): -16.57118810492355
Asset turnover: 0
Equity multiplier (leverage): 1.0837256277177725
ROE archetype: Low Return
Treasury beta 1y: -0.009990253749002786 (R-squared: 0.0017920869470995815)
Insider 90-day net shares: -23407 (net value USD: -341849.00)
ROIC (%): -603.1918173732582 (pretax: -763.533946042099)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 51.89530685920578, ROIC 38.98916967509025, revenue growth 1y , 6m momentum 4.693140794223827
Sector percentiles: P/E , 6m momentum 3.259312320916905
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1048389526690413
Base cash flow: -45192000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for STX.L (Healthcare — Drug Manufacturers - Specialty & Generic, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0007999999999999999
Market cap: 65775732 (USD: 88886124.32432432)
Debt to equity: -1.9987398023479472
Current ratio: 0.9
Interest coverage ratio: -1.3553607552258933
Buffett classification: The Gruesome
Analyst consensus upside (%): 1233480
Rule of 40 score: 57.97378504364167
Altman Z-score: -5.286131519702378 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -8.730803634386008
Total shareholder yield (%): -8.730803634386008 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333408, 3m -34.22222222222223, 6m -46.181818181818194, 12m 18.399999999999984, composite -21.187311713627516 (Moderate Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue growth 1y (%): 66.96957989686393
Revenue CAGR 3y (%): 116.42591384567216
Revenue deceleration: yes
Revenue growth consistency score: 46.01446238574792
Accrual ratio: -0.23609609406676574
FCF conversion rate: 0.2084395355423393
Beneish M-score: -2.363067873108623 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.025004298303588853 (R-squared: 0.010265684389840535)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -231.0008728542333 (pretax: -292.40616816991553)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC 86.80351906158357, revenue growth 1y 3.812316715542522, 6m momentum 83.28445747800586
Sector percentiles: P/E , 6m momentum 68.12320916905445
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -22383783.783783782
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SWAN.V (Basic Materials — Chemicals, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.6312056737588653
Market cap: 49693712 (USD: 35750871.942446046)
P/B ratio: 5.316221246182846
Debt to equity: 0
Current ratio: 35.3
Return on net tangible assets (%): -10.670409912365518
Buffett classification: The Gruesome
Analyst consensus upside (%): 194.4915254237288
Rule of 40 score: 0
Altman Z-score: 137.95328825512613 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -17.008142894667724, 3m -27.937352245862872, 6m -26.181031373963215, 12m , composite -27.059191809913045 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.0031602940833318645
FCF conversion rate: 1.0416052069738515
Beneish M-score: -2.279456620938027 (Likely Safe)
ROE (%): -7.808172848146216
Asset turnover: 0
Equity multiplier (leverage): 1.0279443585586623
ROE archetype: Low Return
Treasury beta 1y: 0.00594949599004245 (R-squared: 0.0021822547055702825)
Insider 90-day net shares: 184000 (net value USD: 112176.00)
ROIC (%): -106.30050274129287 (pretax: -134.55759840669984)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 73.48484848484848, ROIC 90.9090909090909, revenue growth 1y , 6m momentum 80.3030303030303
Sector percentiles: P/E , 6m momentum 50.777345918933925
Industry median P/E: 0.21362271362271362; industry median ROIC: 4.746285835859994
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -4799708.02919708
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SYR.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.0763888888888889
Market cap: 255412016 (USD: 171417460.40268457)
P/B ratio: 2.4235676472412133
Debt to equity: 0.9002
Current ratio: 0.67
Interest coverage ratio: -2.296392711044998
Return on net tangible assets (%): -26.066778237086137
Buffett classification: The Gruesome
Analyst consensus upside (%): -21.117647058823543
Rule of 40 score: -171.8137378487122
Altman Z-score: -1.32982932544966 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.6777284902680538
Debt paydown yield (%): -17.00840712519583
Total shareholder yield (%): -16.33067863492778 (Minimal or Negative)
Momentum (%): 1m -7.696759259259251, 3m -10.879629629629624, 6m -61.542145593869726, 12m -70.42378917378917, composite -46.79311163506566 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue growth 1y (%): 14.447907997727372
Revenue CAGR 3y (%): -32.156118083684106
Revenue deceleration: no
Revenue growth consistency score: 36.350571610168544
Accrual ratio: -0.05694575992798839
FCF conversion rate: 0.6176648818334443
Beneish M-score: 1.8931921959005527 (Strong Manipulation Signal)
ROE (%): -29.629545463645023
Net margin (%): -301.5577723854888
Asset turnover: 0.04939086996014706
Equity multiplier (leverage): 1.9893343736899065
ROE archetype: Low Return
Treasury beta 1y: 0.003166019488837903 (R-squared: 0.00019853928763513906)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -12.603250118105588 (pretax: -15.953481162158969)
Incremental ROIC 3y (%): -44.79484136699899 (pretax: -56.702330844302516)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 31.64029975020816, ROIC 28.476269775187347, revenue growth 1y 5.162364696086595, 6m momentum 74.27144046627811
Sector percentiles: P/E , 6m momentum 78.90061077179344
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.09951742264166316
Base cash flow: -57598657.71812081
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for T92.AX (Energy — Uranium, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.02777777777777778
Market cap: 6528084 (USD: 4266721.568627451)
Current ratio: 0.78
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -19.444444444444436, 3m -51.38888888888889, 6m -49.30555555555556, 12m 4.861111111111119, composite -23.507343550447004 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.00045348004580717416 (R-squared: 1.4452199958586322e-06)
Insider 90-day net shares: 1977589 (net value USD: 110846.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 59.756097560975604
Sector percentiles: P/E , 6m momentum 74.13280475718534
Industry median P/E: 18.936598557423494; industry median ROIC: -13.899740371778044
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.09805
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for TGEN (Industrials — Electrical Equipment & Parts, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 3.18
Market cap: 96335808 (USD: 96335808)
P/B ratio: 3.919625128255334
Debt to equity: 0.1461
Current ratio: 3.02
Interest coverage ratio: -62.30478331970564
Return on net tangible assets (%): -11.578335459189116
Buffett classification: The Gruesome
Analyst consensus upside (%): 244.921875
Rule of 40 score: -32.724529343746724
Altman Z-score: 2.1140768812884945 (Grey Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.04101071119889294
Total shareholder yield (%): -0.04101071119889294 (Minimal or Negative)
Momentum (%): 1m -40.89219330855018, 3m -25.87412587412587, 6m -26.728110599078335, 12m -61.91616766467066, composite -29.390366249551096 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 9, recommendation: Short
Revenue growth 1y (%): -12.94353902362949
Revenue deceleration: no
Revenue growth consistency score: 23.26240802900903
Accrual ratio: 0.028985683703170312
FCF conversion rate: 1.4887931258274707
Beneish M-score: -2.1959288446185354 (Likely Safe)
ROE (%): -10.331693314283966
Net margin (%): -33.43958720717248
Asset turnover: 0.17733626267917588
Equity multiplier (leverage): 1.742260324750349
ROE archetype: Low Return
Treasury beta 1y: 0.006196650463441555 (R-squared: 0.00056042366251289)
Insider 90-day net shares: 17723 (net value USD: 73232.00)
ROIC (%): -47.511362114568364 (pretax: -60.140964701985254)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 50, ROIC 75.40322580645162, revenue growth 1y 53.62903225806451, 6m momentum 66.93548387096774
Sector percentiles: P/E , 6m momentum 74.47516641065029
Industry median P/E: 0.45393488063562387; industry median ROIC: 7.054948446910231
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.15
Base cash flow: -7767571
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for TGO.TO (Communication Services — Telecom Services, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.921985815602837
Market cap: 50746304 (USD: 36508132.37410072)
P/B ratio: 14.665134102997017
Debt to equity: 21.003800000000002
Current ratio: 1.27
Interest coverage ratio: -0.5628654970760234
Buffett classification: The Gruesome
Analyst consensus upside (%): 95.22471910112358
Rule of 40 score: -15.331792701435605
Altman Z-score: -3.3359601515124755 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.2457129580738355
Total shareholder yield (%): -1.2457129580738355 (Minimal or Negative)
Momentum (%): 1m 2.282801418439726, 3m 35.819415846869546, 6m 59.04255319148935, 12m 1.9431470910454025, composite 31.509965098362088 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): -1.0038741691398845
Revenue deceleration: no
Accrual ratio: -0.03783210676375975
FCF conversion rate: 0.29518648390181706
Beneish M-score: -2.6616599466505373 (Likely Safe)
ROE (%): -77.91097240741064
Net margin (%): -50.82631237848347
Asset turnover: 0.10560821481045916
Equity multiplier (leverage): 14.514842313169234
ROE archetype: Low Return
Treasury beta 1y: 0.0043538475335929226 (R-squared: 0.0005729561890296612)
Insider 90-day net shares: 93750 (net value USD: 92321.00)
ROIC (%): -13.127522780557374 (pretax: -16.61711744374351)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 55.46218487394958, ROIC 64.70588235294117, revenue growth 1y 36.97478991596639, 6m momentum 2.941176470588235
Sector percentiles: P/E , 6m momentum 2.8478437754271764
Industry median P/E: 6.173333333333333; industry median ROIC: 6.697966332884982
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.11548636755455832
Base cash flow: -8280291.970802919
DCF price per share: base 0, conservative 0, aggressive 0